Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02062853 · ClinicalTrials.gov registry record · NA

Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video

A NA study of Actinic Keratoses, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT02062853 is a NA study of Actinic Keratoses that has completed, run by University of California, Davis. The registered enrollment target is 44 participants, below the 94-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02062853, a NA study of Actinic Keratoses, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to evaluate the effects of prospective patient education on patient satisfaction with administration of topical 5% 5-fluorouracil cream for the treatment of actinic keratosis involving the face, scalp, upper chest, dorsal hands and forearms. Specifically, this study aims to determine if prospective patient viewing of an educational video delineating treatment effects and expectations improves patient satisfaction and treatment completion rates.

Conditions Studied

Interventions

  • OTHER Video Group
  • OTHER Verbal Group

Study Locations (1)

California

  • University of California-Davis, Department of Dermatology - Sacramento

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2012-11
Est. Completion 2016-06
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT02062853

The ClinicalTrials.gov registry entry for NCT02062853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 94-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (53% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Actinic Keratoses appearing as the primary indexed condition, and to 2 interventions - of which Video Group is the first listed.

NCT02062853 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02062853 about?

NCT02062853 is a clinical study titled "Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video". The primary aim of this study is to evaluate the effects of prospective patient education on patient satisfaction with administration of topical 5% 5-fluorouracil cream for the treatment of actinic keratosis involving the face, scalp, upper chest, dorsal hands and forearms. Specifically, this study ...

What is the current status of trial NCT02062853?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2012-11. Estimated completion is 2016-06.

What conditions does trial NCT02062853 study?

This clinical trial studies the following conditions: Actinic Keratoses.

What interventions are being tested in trial NCT02062853?

The interventions under investigation include: Video Group (OTHER), Verbal Group (OTHER).

Who is sponsoring clinical trial NCT02062853?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02062853 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Actinic Keratoses

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.